Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design of a stable human acid‐β‐glucosidase: towards improved Gaucher disease therapy and mutation classification
Šárka Pokorná, Olga Khersonsky, Rosalie Lipsh‐Sokolik, et al.
FEBS Journal (2023) Vol. 290, Iss. 13, pp. 3383-3399
Open Access | Times Cited: 10

Showing 10 citing articles:

Opportunities and challenges in design and optimization of protein function
Dina Listov, Casper A. Goverde, Bruno E. Correia, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 8, pp. 639-653
Closed Access | Times Cited: 33
Effect of Fold-Promoting Mutation and Signal Peptide Screening on Recombinant Glucan 1,4-Alpha-maltohydrolase Secretion in Pichia pastoris
Siyi Wang, Kai Zhu, Pulin Liu
Applied Biochemistry and Biotechnology (2025)
Closed Access
Activation and Purification of ß‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
Jan Philipp Dobert, Simon Bub, Rebecca Mächtel, et al.
Advanced Science (2024) Vol. 11, Iss. 25
Open Access | Times Cited: 3
Identification and characterization of nanobodies acting as molecular chaperones for glucocerebrosidase through a novel allosteric mechanism
Thomas Dal Maso, Chiara Sinisgalli, Gianluca Zilio, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Efficacy of an AAV vector encoding a thermostable form of glucocerebrosidase in alleviating symptoms in a Gaucher disease mouse model
Ivan Milenković, Shani Blumenreich, Ariel Hochfelder, et al.
Gene Therapy (2024) Vol. 31, Iss. 9-10, pp. 439-444
Open Access | Times Cited: 1
Functional Analysis of Human GBA1 Missense Mutations in Drosophila: Insights into Gaucher Disease Pathogenesis and Phenotypic Consequences
Aparna Kuppuramalingam, Or Cabasso, Mia Horowitz
Cells (2024) Vol. 13, Iss. 19, pp. 1619-1619
Open Access | Times Cited: 1
Engineering Synthetic and Recombinant Human Lysosomal b-Glucocerebrosidase for Enzyme Replacement Therapy for Gaucher Disease
Lílian Louise Souza Figueiredo, Wilson Lau Júnior, Victor Wendel da Silva Gonçalves, et al.
Research Square (Research Square) (2024)
Closed Access
Engineering synthetic and recombinant human lysosomal β-glucocerebrosidase for enzyme replacement therapy for Gaucher disease
L Figueiredo, Wilson Lau, Victor Wendel da Silva Goncalves, et al.
Deleted Journal (2024) Vol. 6, Iss. 10
Open Access
Revisiting the diagnosis of Gaucher disease in a family with multiple GBA1 variants
Emory Ryan, Nahid Tayebi, Andrea D'Souza, et al.
American Journal of Medical Genetics Part A (2023) Vol. 191, Iss. 10, pp. 2647-2650
Closed Access
Comparative physicochemical and biological characterization of the similar imiglucerase product Glurazyme® and the originator product Cerezyme®
Maksim Smolov, Serge Taran, I. V. Lyagoskin, et al.
Journal of Pharmaceutical and Biomedical Analysis Open (2023) Vol. 3, pp. 100024-100024
Open Access
Page 1

Scroll to top